Concepedia

Olivia Naismith

ON

Statistics

Publications

29

Citations

3.5K

H-Index

21

Active since

1997

Affiliations

Institute of Cancer Research(Current)

Clatterbridge Cancer Centre NHS Foundation Trust

Royal Marsden NHS Foundation Trust

Cardiff University

Royal Marsden Hospital

Olivia Naismith is an author at Institute of Cancer Research specializing in medicine, radiation therapy, and radiation oncology.

Publications per year

1997–2025

29

Publications

29

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

David P. Dearnaley, Isabel Syndikus, Helen Mossop et al. · The Lancet Oncology · 2016 · 1.3K citations · Full text

, , +17

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler et al. · The Lancet Oncology · 2019 · 536 citations · Full text

, , +17

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial

David P. Dearnaley, Isabel Syndikus, G. Sumo et al. · The Lancet Oncology · 2011 · 308 citations · Full text

, , +17

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Alison Tree, Peter Ostler, H. van der Voet et al. · The Lancet Oncology · 2022 · 303 citations · Full text

, , +16

Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer

Nicholas van As, Clare Griffin, Alison Tree et al. · New England Journal of Medicine · 2024 · 218 citations · Full text

, , +16

1–5 of 29